Cited by 903Cardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.

Molecular mechanisms of diabetic cardiomyopathy

Open access

Bugger, Heiko, Abel, E. Dale·2014·Diabetologia

DOI 10.1007/s00125-014-3171-6PMC PMC3969857

Open this paper in CoChat — free account Open PDF

Abstract

In recent years, diabetes mellitus has become an epidemic and now represents one of the most prevalent disorders. Cardiovascular complications are the major cause of mortality and morbidity in diabetic patients. While ischaemic events dominate the cardiac complications of diabetes, it is widely recognised that the risk for developing heart failure is also increased in the absence of overt myocardial ischaemia and hypertension or is accelerated in the presence of these comorbidities. These diabetes-associated changes in myocardial structure and function have been called diabetic cardiomyopathy. Numerous molecular mechanisms have been proposed to contribute to the development of diabetic cardiomyopathy following analysis of various animal models of type 1 or type 2 diabetes and in genetically modified mouse models. The steady increase in reports presenting novel mechanistic data on this subject expands the list of potential underlying mechanisms. The current review provides an update on molecular alterations that may contribute to the structural and functional alterations in the diabetic heart.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3171-6

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts
Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., & Wang, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700015200 · Cited by 233
Retracted
Retracted: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 154
Retracted
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
The Framingham Study
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520

Show all 153 references

Sorted by citations

Items 501–600 of 903

Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
Zhu, N., Huang, B., Zhu, L., & Wang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9944589 · Cited by 14
Cellular and molecular mechanisms, genetic predisposition and treatment of diabetes-induced cardiomyopathy
Sharma, U., Chakraborty, M., Chutia, D., & Bhuyan, N. R. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100126 · Cited by 14
MG53 and disordered metabolism in striated muscle
Hu, X., & Xiao, R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.013 · Cited by 13
O-GlcNAc transferase affects the signal transduction of β1 adrenoceptor in adult rat cardiomyocytes by increasing the O-GlcNAcylation of β1 adrenoceptor
Cao, H. W., Hu, Y., Zhu, X., Yao, N., Gu, J., Wang, Y., & Zhu, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.010 · Cited by 14
Increased cardiac PFK-2 protects against high-fat diet-induced cardiomyopathy and mediates beneficial systemic metabolic effects
Garcia, M. F. M., Matsuzaki, S., Batushansky, A., Newhardt, R., Kinter, C. S., Jin, Y., Mann, S. N., Stout, M. B., Gu, H., Chiao, Y. A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107131 · Cited by 13
A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy
Dhar, A., Venkadakrishnan, J., Roy, U., Vedam, S., Lalwani, N., Ramos, K. S., Pandita, T. K., & Bhat, A. (2023) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447231210170 · Cited by 15
Adeno-Associated Viral Transfer of Glyoxalase-1 Blunts Carbonyl and Oxidative Stresses in Hearts of Type 1 Diabetic Rats
Alomar, F. A., Al‐Rubaish, A. M., Al‐Muhanna, F., Al‐Ali, A. K., McMillan, J., Singh, J., & Bidasee, K. R. (2020) · Antioxidants · doi:10.3390/antiox9070592 · Cited by 13
Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats
Khan, M. A. H., Hwang, S. H., Barnett, S. D., Stavniichuk, A., Jankiewicz, W. K., Hammock, B. D., & Imig, J. D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15623 · Cited by 13
RETRACTED: Decrypting the circular RNAs does a favor for us: Understanding, diagnosing and treating diabetes mellitus and its complications
Li, Z., Ren, Y., Lv, Z., Li, M., Li, Y., Fan, X., Xiong, Y., & Lü, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115744 · Cited by 13
Retracted
Identification of miR‑145 as a regulator of the cardiomyocyte inflammatory response and oxidative stress under hyperglycemia
Zheng, W., Li, T., Wei, J., Zhang, Y., Zuo, Q., & Lin, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9898 · Cited by 13
Sleeve Gastrectomy-Induced AMPK Activation Attenuates Diabetic Cardiomyopathy by Maintaining Mitochondrial Homeostasis via NR4A1 Suppression in Rats
Li, S., Dong, S., Xu, Q., Shi, B., Li, L., Zhang, W., Zhu, J., Cheng, Y., Zhang, G., & Zhong, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.837798 · Cited by 13
Treatment of diabetes and heart failure: joint forces
Swedberg, K. B., & Rydén, L. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw039 · Cited by 15
Signal transduction mechanism of exosomes in diabetic complications (Review)
Li, X., Shi, S., Jing, D., Li, X., Zhang, B., & Bie, Q. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.11078 · Cited by 12
Swimming alleviates myocardial fibrosis of type II diabetic rats through activating miR-34a-mediated SIRT1/PGC-1α/FNDC5 signal pathway
Guo, Y., Zhou, F., Fan, J., Wu, T., Jia, S., Li, J., & Chen, N. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310136 · Cited by 21
TiOx(OH)4–2x Nanosheets with Catalytic Antioxidative Activity Alleviate Oxidative Injury in Diabetic Cardiomyopathy
Yao, Y., Yang, B., & Shi, J. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18026 · Cited by 12
Ferroptosis as an Emerging Target in Diabetic Osteoporosis
Li, C., Gong, H., Zhang, Y., Shi, P., Liu, S., & Zhang, Q. (2025) · The FASEB Journal · doi:10.1096/fj.202500415r · Cited by 13
Identification of biomarkers and mechanisms of diabetic cardiomyopathy using microarray data
Li, H., Li, X., Guo, J., Wu, G., Dong, C., Pang, Y., Gao, S., & Wang, Y. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0113 · Cited by 12
Presence of fragmented QRS may be associated with complex ventricular arrhythmias in patients with type-2 diabetes mellitus
Eren, H., Ülker, K. A. Y. A., Öcal, L., Öcal, A., Genç, Ö., Genç, S., & Evlıce, M. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2019.1693117 · Cited by 14
Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT‐FoxO1 signalling pathway
Wang, J., Bai, J., Duan, P., Wang, H., Li, Y., & Zhu, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16346 · Cited by 12
Role of Some Serum Biomarkers in the Early Detection of Diabetic Cardiomyopathy
Abdelrahman, A. H., Salama, I. I., Salama, S. I., Elmosalami, D. M., Ibrahim, M. H., Hassan, E. M., Dimitry, M. O., Aboafya, Z. I., Mohammad, M. G., & Amin, M. I. (2021) · Future Science OA · doi:10.2144/fsoa-2020-0184 · Cited by 12
Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response
Dato, V. A., Benitez‐Amaro, A., Garcı́a, E., Claudi, L., Lhoëst, M. T. L. C., Iborra, A., Escolá‐Gil, J. C., Palmero, M. J. G., Samouillan, V., Enrich, C., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113270 · Cited by 12
Microbial Phenolic Metabolites in Urine Are Inversely Linked to Certain Features of Metabolic Syndrome in Spanish Adolescents
Santos, E. P. L., Quifer‐Rada, P., Marhuenda‐Muñoz, M., Arancibia‐Riveros, C., Vallverdú‐Queralt, A., Tresserra‐Rimbau, A., Ruiz-León, A. M., Casas, R. M., Estruch, R., Bodega, P., et al. (2022) · Antioxidants · doi:10.3390/antiox11112191 · Cited by 12
An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches
Vig, H., Ravinandan, A. P., Vishwas, H. N., Tyagi, S., Rathore, S., Wal, A., & Wal, P. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230502110511 · Cited by 12
Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy
Jin, B. R., Wang, J., Chen, Y., Zuo, W., Hong, B., Li, J., Huang, F., Zhang, M., & Wang, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110280 · Cited by 12
Effect of acid-sensing ion channel 1a on the process of liver fibrosis under hyperglycemia
Wang, H., Wang, Y.-H., Yang, F., Li, X., Tian, Y., Ni, M.-M., Zuo, L., Meng, X., & Huang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.029 · Cited by 12
Panvascular risk factor - Diabetes
Ramalingam, V., & Vijayvergiya, R. (2018) · Cor et Vasa · doi:10.1016/j.crvasa.2018.01.004 · Cited by 12
Effects of GCN2/eIF2α on myocardial ischemia/hypoxia reperfusion and myocardial cells injury.
Pu, Y., Wu, D., Lu, X., & Yang, L. (2019) · PubMed Central · Cited by 12
LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells
Dato, V. A., Benitez‐Amaro, A., de Gonzalo‐Calvo, D., Vazquez, M., Bonacci, G., Llorente‐Cortés, V., & Chiabrando, G. A. (2020) · Cells · doi:10.3390/cells9010182 · Cited by 12
Effect of adenosine monophosphate‐activated protein kinase–p53–Krüppel‐like factor 2a pathway in hyperglycemia‐induced cardiac remodeling in adult zebrafish
Wang, Q., Luo, C., Lü, G., & Chen, Z. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13393 · Cited by 12
Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy
Richter, C., & Hinkel, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.703355 · Cited by 12
Transcriptomics Coupled to Proteomics Reveals Novel Targets for the Protective Role of Spermine in Diabetic Cardiomyopathy
Wei, C., Song, T., Yuan, H. S., Li, X., Zhang, X., Xiao, L., & Fan, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5909378 · Cited by 12
Interplay between Senescence and Macrophages in Diabetic Cardiomyopathy: A Review of the Potential Role of GDF-15 and Klotho
Almohaimeed, G. M., Alonazi, A. S., Dayel, A. F. B., Alshammari, T. K., Alghibiwi, H. K., Alamin, M. A., Almotairi, A. R., & Al-Rasheed, N. M. (2024) · Biomedicines · doi:10.3390/biomedicines12040759 · Cited by 11
MiR214-3p Ameliorates Diabetic Cardiomyopathy by Inhibiting Ferroptosis
Chen, P., Huang, X., Wen, W., Cao, Y., Li, W., Huang, G., Huang, Y., Hu, Y., & Ma, T. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-09992-4 · Cited by 11
Impaired cardiac branched-chain amino acid metabolism in a novel model of diabetic cardiomyopathy
Asakura, J., Nagao, M., Shinohara, M., Hosooka, T., Kuwahara, N., Nishimori, M., Tanaka, H., Satomi‐Kobayashi, S., Matsui, S., Sasaki, T., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02725-5 · Cited by 11
PI3Kγ Inhibition Protects Against Diabetic Cardiomyopathy in Mice
Maffei, A., Cifelli, G., Carnevale, R., Iacobucci, R., Pallante, F., Fardella, V., Fardella, S., Hirsch, E., Lembo, G., & Carnevale, D. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.04.034 · Cited by 11
Potential Therapeutic Effect of Citronellal on Diabetic Cardiomyopathy in Experimental Rats
Lu, J., Qiu, Y., Guo, L., Song, P., Xu, J. C., Wan, G., Wang, S., Yin, Y., & Li, P. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9987531 · Cited by 11
Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA)
Echouffo-Tcheugui, J. B., Ogunmoroti, O., Golden, S. H., Bertoni, A. G., Mongraw‐Chaffin, M., Pandey, A., Ndumele, C. E., & Michos, E. D. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.01.011 · Cited by 11
Revisiting bungur (Lagerstroemia speciosa) from Indonesia as an antidiabetic agent, its mode of action, and phylogenetic position
Nurcahyanti, A. D. R., Arieselia, Z., Kurniawan, S. V., Sofyan, F., & Wink, M. (2018) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/phrev.phrev_20_17 · Cited by 11
Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia
Heitmeier, M. R., Payne, M., Weinheimer, C. J., Kovács, A. D., Hresko, R. C., Jay, P. Y., & Hruz, P. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-24867-1 · Cited by 11
Global longitudinal strain as a marker for systolic function in patients with pheochromocytomas
Elenkova, A. P., Shabani, R. A., Kinova, E., Vasilev, V., Goudev, A., & Zacharieva, S. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0137 · Cited by 11
Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice
Daltro, P. S., Alves, P. S., de Castro, M. F., Azevedo, C. M., Vasconcelos, J. F., Allahdadi, K. J., de Freitas, L. A. R., Souza, B. S. D. F., dos Santos, R. R., Soares, M. B. P., et al. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0154-6 · Cited by 12
Nanoliposome-based drug delivery systems for the treatment of diabetes mellitus: a review
Umar, M., Sherazi, T. A., Talha, M., Ramadan, M. F., Ahmed, A. E., Taha, R., & Naqvi, S. A. R. (2025) · RSC Advances · doi:10.1039/d5ra07152f · Cited by 10
Mechanism of XiJiaQi in the treatment of chronic heart failure: Integrated analysis by pharmacoinformatics, molecular dynamics simulation, and SPR validation
Zhao, D., Guo, K., Zhang, Q., Wu, Y., Ma, C., He, W., Jin, X., Zhang, X., Wang, Y., Lin, S., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107479 · Cited by 10
Association of major and minor ECG abnormalities with traditional cardiovascular risk factors in the general population: a large scale study
Sahranavard, T., Alimi, R., Arabkhazaei, J., Nasrabadi, M., Dana, S. M. M. A., Gholami, Y., Izadi‐Moud, A., Esmaily, H., Ebrahimi, M., Ferns, G. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62142-8 · Cited by 10
Mitochondrial complex-1 as a therapeutic target for cardiac diseases
Rai, N. K., Venugopal, H., Rajesh, R., Ancha, P., & Venkatesh, S. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05074-1 · Cited by 12
Ferritinophagy in cardiovascular diseases: mechanisms and potential therapy
Wang, S., Yu, Z.-Z., Ye, L., Xiao, D., Wang, P., Wang, Y., & Wang, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05301-3 · Cited by 10
UCP2 inhibition exaggerates diabetic cardiomyopathy by facilitating the activation of NLRP3 and pyroptosis
Zhang, L., Ai, C., Guo, C., Li, S., Niu, J., Meng, X., & Zhang, Z. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01855-w · Cited by 10
Protective effect of glucagon-like peptide-1 mediated by ultrasound microbubbles on myocardial injury in rats with diabetic cardiomyopathy
Liu, Y., Chen, L., Wu, H., & Zhang, H. (2022) · Bioengineered · doi:10.1080/21655979.2021.2022270 · Cited by 10
Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
Tokarek, J., Budny, E., Saar, M., Stańczak, K., Wojtanowska, E., Młynarska, E., Rysz, J., & Franczyk, B. (2023) · Biomedicines · doi:10.3390/biomedicines11102611 · Cited by 12
Diabetes mellitus and heart disease
Chandrasekaran, P., & Weiskirchen, R. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.15 · Cited by 10
Epigenetics in the Development of Diabetic Cardiomyopathy
Pepin, M. E., & Wende, A. R. (2019) · Epigenomics · doi:10.2217/epi-2019-0027 · Cited by 10
Silent myocardial dysfunction in vitamin D deficiency
Özer, P. K., Emet, S., Karaayvaz, E. B., Elitok, A., Bilge, A. K., Adalet, K., & Öncül, A. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.97110 · Cited by 10
Diabetes induced decreases in PKA signaling in cardiomyocytes: The role of insulin
Eyster, C. A., Matsuzaki, S., Newhardt, M. F., Giorgione, J. R., & Humphries, K. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231806 · Cited by 10
Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial
Gohari, S., Reshadmanesh, T., Khodabandehloo, H., Fathi, M., Ahangar, H., Arsang‐Jang, S., Ismail‐Beigi, F., Ghanbari, S., Dadashi, M., Muhammadi, M. J., et al. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02131-1 · Cited by 10
Increased myofilament calcium sensitivity is associated with decreased cardiac troponin I phosphorylation in the diabetic rat heart
Greenman, A., Diffee, G. M., Power, A., WILKINS, G. T., Gold, O. M. S., Erickson, J. R., & Baldi, J. C. (2021) · Experimental Physiology · doi:10.1113/ep089730 · Cited by 12
Hydroxyurea protects against diabetic cardiomyopathy by inhibiting inflammation and apoptosis
Zhou, Y., & Lu, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113291 · Cited by 10
Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
Adel, F., Ye, Z., Wan, S., Greason, C. M., Pan, S., Ameenuddin, S., & Chen, H. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.890907 · Cited by 10
Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome
Berk, J., Wade, R. C., Başer, H. D., & Lado, J. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0112-3 · Cited by 10
Caloric restriction in heart failure: A systematic review
Bianchi, V. E. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.04.009 · Cited by 11
Regional Expert Opinion: Management of Heart Failure with Preserved Ejection Fraction in the Middle East, North Africa and Turkey
Abdelhamid, M., Alghalayini, K. W., Alhumood, K. A., Altun, B., Arafah, M., Bader, F. M., Ibrahim, M. F., Sabbour, H. M., Shawky, A., Skouri, H. N., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14456 · Cited by 9
Cardioprotective role of diacerein in diabetic cardiomyopathy via modulation of inflammasome/caspase1/interleukin1β pathway in juvenile rats
Refaie, M. M. M., Mohammed, H. H., Abdel‐Hakeem, E. A., Bayoumi, A. M. A., Mohamed, Z. H., & Shehata, S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02921-8 · Cited by 9
Overview on chronic complications of diabetes mellitus
Vlacho, B., Rossell-Rusiñol, J., Granado-Casas, M., Mauricio, D., & Julve, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00009-9 · Cited by 11
Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
Shi, M., Zhao, B., Cai, W., Yuan, H. S., Liang, X., Li, Z., Liu, X., Ye, J., Liu, X., & Wei, C. (2024) · mSystems · doi:10.1128/msystems.01450-24 · Cited by 9
Luteolin alleviates diabetic cardiac injury related to inhibiting SHP2/STAT3 pathway
Pan, J., Chen, M., Jiang, C., Zhang, Z.-Y., Yan, J.-L., Meng, X., Han, Y.-P., Lou, Y.-Y., Yang, J.-T., & Qian, L.-B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177259 · Cited by 9
Mechanistic underpinnings of AGEs-RAGE via DIAPH1 in ischemic, diabetic, and failing hearts
Yepuri, G., Hasan, S. N., Kumar, V. S., Manigrasso, M. B., Theophall, G. G., Shekhtman, A. G., Schmidt, A. M., & Ramasamy, R. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00685.2024 · Cited by 9
Different Forms of Regulated Cell Death in Type-2-Diabetes-Mellitus-Related Osteoporosis: A Focus on Mechanisms and Therapeutic Strategies
Li, C., Gong, H., Shi, P., Liu, S., & Zhang, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094417 · Cited by 10
From Type 2 Diabetes Mellitus To Diabetic Cardiomyopathy – A Systematic Review On The Role Of MicroRNA
Żarek-Starzewska, A., Klimczak‐Tomaniak, D., Mądrecka, A. J., Sygitowicz, G., Janiszewski, M., & Kuch, M. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01590-6 · Cited by 9
Inflammatory signalling in diabetic cardiomyopathy: molecular mechanisms and potential therapeutic strategies
Blasio, M. J. D., & Ritchie, R. H. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01274-y · Cited by 9
The multifaceted roles of ER and Golgi in metabolic cardiomyopathy
Raja, R., Fonseka, O., Ganenthiran, H., Ruiz‐Velasco, A., & Liu, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.999044 · Cited by 10
Ethanol extract of propolis alleviates diabetic cardiomyopathy via JAK2/STAT3 signaling pathway
Shi, P., Du, T., Meng, F., Xie, S., Han, S., Yang, J., Zhang, Y., Sun, Y., Gong, J., & Yao, H. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105688 · Cited by 9
Ultrasound-targeted semaglutide-loaded PEG-nanoliposomes microbubble destruction protects diabetic cardiomyopathy by activating PI3K/Akt/Nrf2 signaling pathway
Zhu, J., Wang, H., Yan, C., Li, B., & Chen, B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19873 · Cited by 9
Ginsenoside Rb1 alleviates chronic intermittent hypoxia-induced diabetic cardiomyopathy in db/db mice by regulating the adenosine monophosphate-activated protein kinase/Nrf2/heme oxygenase-1 signaling pathway.
Bingbing, L., Li, J.-R., Si, J., Chen, Q., Shengchang, Y., & Ji, E. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20221206.004 · Cited by 9
Apoptosis and long non-coding RNAs: Focus on their roles in Heart diseases
Al‐Masri, A. A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154889 · Cited by 9
Lanosteryl triterpenes from Protorhus longifolia as a cardioprotective agent: a mini review
Sangweni, N. F., Dludla, P. V., Mosa, R. A., Kappo, A. P., Opoku, A. R., Muller, C. J. F., & Johnson, R. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9733-9 · Cited by 9
Unveiling the Vital Role of Long Non-Coding RNAs in Cardiac Oxidative Stress, Cell Death, and Fibrosis in Diabetic Cardiomyopathy
Tian, Y., Gao, Z., Liu, W., Li, J., Jiang, X. M., & Xin, Y. (2022) · Antioxidants · doi:10.3390/antiox11122391 · Cited by 10
Bibliometric analysis of the inflammation in diabetic cardiomyopathy
Zhu, N., Huang, B., & Zhu, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1006213 · Cited by 9
Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy
Dayel, A. F. B., Alonazi, A. S., Al‐Rasheed, N. M., Alamin, M. A., Sarawi, W. S., Alharbi, A. O., Alabbad, N. A., Albuaijan, D. A., Alassiri, D., Aljarbua, A. F., et al. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad111 · Cited by 9
3-Weeks of Exercise Training Increases Ischemic-Tolerance in Hearts From High-Fat Diet Fed Mice
Boardman, N. T., Rossvoll, L., Lund, J., Hafstad, A. D., & Aasum, E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01274 · Cited by 9
Comparative study of the efficacy of captopril, simvastatin, and L-carnitine as cardioprotective drugs in children with type 1 diabetes mellitus: a randomised controlled trial
Badreldeen, A. S., Razaky, O. E., Erfan, A. A., El-Bendary, A. S., & Amrousy, D. M. E. (2021) · Cardiology in the Young · doi:10.1017/s1047951121000226 · Cited by 9
Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference
Liu, P., Yang, Z., Wang, Y., & Sun, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713188 · Cited by 8
GSTM2 alleviates heart failure by inhibiting DNA damage in cardiomyocytes
Xu, H., Wang, Z., Wang, Y., Pan, S., Zhao, W., Chen, M., Chen, X., Tao, T., Ma, L., Ni, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01168-3 · Cited by 8
Harnessing the therapeutic potential of exercise in extracellular vesicle-based therapy in metabolic disease associated cardiovascular complications
Perera, N., Blasio, M. J. D., & Febbraio, M. A. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.022 · Cited by 9
Dapagliflozin Suppresses High Glucose-Induced Proliferation, Oxidative Stress, and Fibrosis by Reducing Mettl3-Induced m6A Modification in Marcks mRNA
Shi, B., Wang, J., Zhang, J., Li, J., Yancheng, H., Lin, X., & Zhao, R. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09945-3 · Cited by 8
UBC9 ameliorates diabetic cardiomyopathy by modulating cardiomyocyte mitophagy through NEDD4/RUNX2/PSEN2 axis
Wu, H., Yang, Z., Zhou, T., Wang, J., Bu, Y., Song, H., Yan, C., Liu, D., & Han, Y. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156264 · Cited by 8
High-Fat Diet-Induced Diabetic Cardiomyopathy in Female Zebrafish: Cardiac Pathology and Functional Decline Mediated by Type 2 Diabetes
Huang, S., Chen, Z., Li, H.-M., Zou, Y., Wang, B., Zhao, W., Zheng, L., Zhou, Z., Peng, X., & Tang, C. (2025) · Nutrients · doi:10.3390/nu17132209 · Cited by 8
Diabetic cardiomyopathy: Mechanistic insights on molecular pathways and emerging therapeutic approaches
Kaur, R., Singh, S., Sood, P., Singh, S., Banerjee, S., & Singh, T. G. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10562-7 · Cited by 9
Sodium-Glucose Cotransporter 2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease
Antoun, M. T. B., Borghol, A. H., Souvalian, L., Hadla, M., Abboud, G., Ghanem, A., Debeh, F. G. M., Mardirossian, J. M., Salih, M., Garimella, P. S., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000943 · Cited by 9
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets
Capece, U., Nilo, D., Morciano, C., Nilo, R., Spiezia, S., Sircana, M. C., Russo, V., Perrone, M. A., Bonfrate, L., Acierno, C., et al. (2026) · Biomolecules · doi:10.3390/biom16030470 · Cited by 11
miR-190 protects cardiomyocytes from apoptosis induced by H2O2 through targeting MAPK8 and regulating MAPK8/ERK signal pathway.
Zhai, C., Tang, G.-M., Qian, G., Han, B., Hu, H., Wang, S., Yin, D., Pan, H., & Zhang, S. (2018) · Europe PMC (PubMed Central) · Cited by 8
Reactive Oxygen Species-Mediated Diabetic Heart Disease: Mechanisms and Therapies
Reily-Bell, M., Bahn, A., & Katare, R. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0098 · Cited by 8
The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis
Geng, X., Shang, W.-Y., Qi, Z., Zhang, C., Li, W.-X., Yan, Z., Fan, X., & Zhang, J. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108848 · Cited by 9
ALDH2 Enzyme Deficiency in Diabetic Cardiomyopathy
Hsieh, Y.-W., Lee, A., Sung, K., Chen, X., Lai, H.-H., Chen, Y., Chien, C.-Y., Yeh, H., Chen, C., & Hung, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125516 · Cited by 8
Heart failure and diabetes mellitus: insight into comorbidity
Petunina, N. A., Викторович, Т. И., Trukhina, L. V., Sizova, Z. M., & Zakharova, V. L. (2019) · Diabetes Mellitus · doi:10.14341/dm9784 · Cited by 8
Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy
Zhang, S., Yang, K., Long, Z., Li, W., & Huang, H. (2020) · Medical Science Monitor · doi:10.12659/msm.919029 · Cited by 8
Sex Differences in Progression of Diabetic Cardiomyopathy in OVE26 Type 1 Diabetic Mice
Tang, X., Jiang, S., Zhang, J., Zhou, S., & Zheng, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6961348 · Cited by 8
Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment
Tanaka, A., & Node, K. (2020) · Diabetology International · doi:10.1007/s13340-020-00445-7 · Cited by 7
Escitalopram Ameliorates Cardiomyopathy in Type 2 Diabetic Rats via Modulation of Receptor for Advanced Glycation End Products and Its Downstream Signaling Cascades
Ahmed, L. A., Shiha, N. A., & Attia, A. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.579206 · Cited by 8
Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates
Liu, M., Li, N., Qu, C., Gao, Y., Wu, L., & Hu, L. G. (2021) · Communications Biology · doi:10.1038/s42003-021-01676-3 · Cited by 8
Putative effect of melatonin on cardiomyocyte senescence in mice with type 1 diabetes mellitus
Rahbarghazi‬, R., Farhoudi, M., Youshanlouei, H. R., Hassanpour, M., Rahbarghazi, A., Rezaie, J., & Ahmadi, M. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-00982-9 · Cited by 8
Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals
Liu, Y., Chen, L., Wu, H., & Zhang, H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2050481 · Cited by 8

Authors: Bugger, H., & Abel, E. D.
Affiliations: University of Freiburg (DE)
University of Iowa (US)
Corresponding author: Abel, E. Dale
ORCID: Bugger, Heiko
Abel, E. Dale
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2014-01-30
Volume: 57
Issue: 4
Pages: 660-671
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-014-3171-6
PMC: PMC3969857
OpenAlex: W2006499762
Cited by: 903
References: 153
Citations by year: 2026: 51 · 2025: 76 · 2024: 75 · 2023: 79 · 2022: 95 · 2021: 103 · 2020: 100 · 2019: 66 · 2018: 84 · 2017: 62 · 2016: 54 · 2015: 43 · 2014: 14
FWCI: 9.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL108379, U01HL087947)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: diabetic cardiomyopathy, diabetes mellitus, heart failure, myocardial structure and function, type 1 diabetes, type 2 diabetes, animal models of diabetes, genetically engineered mouse models, cardiovascular complications of diabetes
MeSH terms: Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Humans, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of diabetic cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks